Matches in Nanopublications for { ?s ?p "[Leptin, MUC2, MUC5AC, mTOR and ERK were more frequently immunopositive in mucinous adenocarcinomas compared with mucinous adenomas or mucinous neoplasms of uncertain malignant potential (p < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP376447.RAbGxBB-btE0POcmiumyfvQ0nroZKUA-Urn-lRNr1pCfg130_assertion description "[Leptin, MUC2, MUC5AC, mTOR and ERK were more frequently immunopositive in mucinous adenocarcinomas compared with mucinous adenomas or mucinous neoplasms of uncertain malignant potential (p < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376447.RAbGxBB-btE0POcmiumyfvQ0nroZKUA-Urn-lRNr1pCfg130_provenance.
- NP643916.RASspeaEzgv0dgR_8HyT_4TZRSOzcz845EOf09SDvYKIA130_assertion description "[Leptin, MUC2, MUC5AC, mTOR and ERK were more frequently immunopositive in mucinous adenocarcinomas compared with mucinous adenomas or mucinous neoplasms of uncertain malignant potential (p < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643916.RASspeaEzgv0dgR_8HyT_4TZRSOzcz845EOf09SDvYKIA130_provenance.
- NP644198.RA8_QJnU6BglZFSAR5VCnF-ywZQ00KjPh5JC167juZzIc130_assertion description "[Leptin, MUC2, MUC5AC, mTOR and ERK were more frequently immunopositive in mucinous adenocarcinomas compared with mucinous adenomas or mucinous neoplasms of uncertain malignant potential (p < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644198.RA8_QJnU6BglZFSAR5VCnF-ywZQ00KjPh5JC167juZzIc130_provenance.
- NP952481.RAw3aQ3HHtG5kaBFU89doMMsiSeatfcDwAvWhn2ZNsPOQ130_assertion description "[Leptin, MUC2, MUC5AC, mTOR and ERK were more frequently immunopositive in mucinous adenocarcinomas compared with mucinous adenomas or mucinous neoplasms of uncertain malignant potential (p < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952481.RAw3aQ3HHtG5kaBFU89doMMsiSeatfcDwAvWhn2ZNsPOQ130_provenance.
- NP376629.RAthdNn-lKo9usxLs2XjWxKcX-4u9wQzIC9Ayshy8Baqw130_assertion description "[Leptin, MUC2, MUC5AC, mTOR and ERK were more frequently immunopositive in mucinous adenocarcinomas compared with mucinous adenomas or mucinous neoplasms of uncertain malignant potential (p < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376629.RAthdNn-lKo9usxLs2XjWxKcX-4u9wQzIC9Ayshy8Baqw130_provenance.
- NP952482.RAmIlqMFZxLS1-BTBUgXkMLK0U9AdCV_6n5WVxN1JeaDk130_assertion description "[Leptin, MUC2, MUC5AC, mTOR and ERK were more frequently immunopositive in mucinous adenocarcinomas compared with mucinous adenomas or mucinous neoplasms of uncertain malignant potential (p < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952482.RAmIlqMFZxLS1-BTBUgXkMLK0U9AdCV_6n5WVxN1JeaDk130_provenance.